These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23650423)

  • 1. Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States.
    Yang HP; Anderson WF; Rosenberg PS; Trabert B; Gierach GL; Wentzensen N; Cronin KA; Sherman ME
    J Clin Oncol; 2013 Jun; 31(17):2146-51. PubMed ID: 23650423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.
    Crawford SL; Crandall CJ; Derby CA; El Khoudary SR; Waetjen LE; Fischer M; Joffe H
    Menopause; 2018 Dec; 26(6):588-597. PubMed ID: 30586004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What the Women's Health Initiative has taught us about menopausal hormone therapy.
    Chester RC; Kling JM; Manson JE
    Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.
    Huang WF; Tsai YW; Hsiao FY; Liu WC
    BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time trends in breast cancer and menopause hormone therapy use in New Zealand.
    Farmer R; Fenton A
    Climacteric; 2016; 19(1):42-8. PubMed ID: 26574628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
    Simin J; Tamimi RM; Callens S; Engstrand L; Brusselaers N
    Int J Cancer; 2020 Jul; 147(1):33-44. PubMed ID: 31584190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.
    Brieger KK; Peterson S; Lee AW; Mukherjee B; Bakulski KM; Alimujiang A; Anton-Culver H; Anglesio MS; Bandera EV; Berchuck A; Bowtell DDL; Chenevix-Trench G; Cho KR; Cramer DW; DeFazio A; Doherty JA; Fortner RT; Garsed DW; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Høgdall E; Huntsman DG; Shen H; Jensen A; Johnatty SE; Jordan SJ; Kjaer SK; Kupryjanczyk J; Lambrechts D; McLean K; Menon U; Modugno F; Moysich K; Ness R; Ramus SJ; Richardson J; Risch H; Rossing MA; Trabert B; Wentzensen N; Ziogas A; Terry KL; Wu AH; Hanley GE; Pharoah P; Webb PM; Pike MC; Pearce CL;
    Gynecol Oncol; 2020 Sep; 158(3):702-709. PubMed ID: 32641237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
    Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
    PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions.
    Temkin SM; Mallen A; Bellavance E; Rubinsak L; Wenham RM
    Cancer; 2019 Feb; 125(4):499-514. PubMed ID: 30570740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and breast cancer incidence in Korean women.
    Choi E; Lee JK; Baek JK; Chung Y; Kim H; Yun BH; Seo SK
    Maturitas; 2024 May; 183():107946. PubMed ID: 38412593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal hormone therapy use in 17 European countries during the last decade.
    Ameye L; Antoine C; Paesmans M; de Azambuja E; Rozenberg S
    Maturitas; 2014 Nov; 79(3):287-91. PubMed ID: 25156453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal hormone therapy and breast cancer.
    Santen RJ
    J Steroid Biochem Mol Biol; 2014 Jul; 142():52-61. PubMed ID: 23871991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.
    Du Y; Dören M; Melchert HU; Scheidt-Nave C; Knopf H
    BMC Womens Health; 2007 Oct; 7():19. PubMed ID: 17945013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone therapy in a health maintenance organization before and after women's health initiative hormone trials termination.
    Wegienka G; Havstad S; Kelsey JL
    J Womens Health (Larchmt); 2006 May; 15(4):369-78. PubMed ID: 16724885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future.
    Webb PM; Green AC; Jordan SJ
    Cancer Causes Control; 2017 May; 28(5):365-370. PubMed ID: 28233113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.
    Antoine C; Ameye L; Paesmans M; de Azambuja E; Rozenberg S
    Maturitas; 2016 Feb; 84():81-8. PubMed ID: 26654400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.
    Velentzis LS; Salagame U; Canfell K
    BMC Health Serv Res; 2017 May; 17(1):326. PubMed ID: 28476121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.